SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is facing significant volatility following an announcement of a massive equity offering intended to finance a substantial backlog of AI-related orders. The community remains deeply divided, with some investors viewing the dilution as a necessary step to scale production for rapid growth, while many others are sounding alarms over the company's financial health, management's history of controversy, and the potential for further share price suppression.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing significant investor volatility as strong earnings and a massive backlog are being overshadowed by plans for a major capital raise and increased AI infrastructure spending. While the community remains divided between those viewing the company's aggressive capacity expansion as a long-term goldmine and those concerned about dilution and debt, the stock continues to see intense action from both buyers looking to capitalize on recent pullbacks and traders wary of broader sector headwinds.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is experiencing significant market interest driven by an ongoing AI-driven infrastructure supercycle, with investors closely watching for an anticipated major contract announcement in Kentucky. Community sentiment remains largely bullish, focusing on the company's power-heavy strategy and institutional price target upgrades, even as day-to-day price volatility and short-selling activity spark heated debates among shareholders.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX is experiencing significant volatility driven by the legal challenges and export compliance issues surrounding SMCI, leading to heavy trading volume and speculation regarding potential delisting or further reverse splits. The community remains deeply divided, with some investors aggressively buying the dip in anticipation of a short squeeze or recovery, while others express frustration over decay and losses, warning against holding this leveraged ETF for the long term.

T1 Energy, Inc. engages in providing energy solutions focused on solar module and solar cell manufacturing. It focuses on building an integrated U.S. supply chain for solar and batteries. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

T1 Energy is experiencing heightened volatility and intense social media discussion as traders track its consolidation phase following a massive surge, with bulls aggressively defending key support levels despite ongoing short seller interest and macroeconomic headwinds. The conversation is heavily focused on the company's strategic acquisition of KORE Power to enter the battery storage and AI data center infrastructure markets, which community members view as a pivotal catalyst for long-term growth.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is capturing attention as market participants debate its long-term viability in the nuclear energy sector, specifically as a potential solution to the power-hungry demands of AI and data center infrastructure. While the community remains divided between those betting on institutional accumulation and future commercialization milestones versus skeptics focused on current revenue gaps and management performance, active traders are closely watching the stock's volatility for short-term opportunities.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is seeing intense community debate as the asset struggles to maintain its safe-haven status amid a broader market correction and falling below its 200-day moving average. Investors are actively discussing the impact of rising bond yields and geopolitical uncertainty, with many split between viewing the recent price drop as an overextended sell-off opportunity or a sign of deeper structural weakness in the gold market.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market participants are reacting to escalating geopolitical tensions in the Middle East alongside conflicting reports regarding potential diplomatic breakthroughs. Trading sentiment remains highly volatile, with the community closely tracking overnight price action and rhetoric as traders navigate the uncertainty surrounding upcoming economic data and policy decisions.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is attracting significant market interest as it balances rapid revenue growth from its core IBSRELA franchise with ongoing institutional speculation regarding potential M&A activity and the impact of the ongoing CMS litigation. Investors are closely monitoring the company's path toward sustained profitability while actively discussing the strategic implications of recent institutional positioning and the potential for a favorable shift in regulatory tailwinds.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 (DXYZ) is experiencing intense investor scrutiny due to its direct exposure to high-profile companies like SpaceX and Anthropic, with sentiment heavily influenced by the upcoming SpaceX IPO. While some investors are concerned about dilution and valuation premiums, the community is actively debating the fund's potential as a unique proxy for these major IPO events as it navigates significant volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is Editas (EDIT) Down 12.4% Since Last Earnings Report?

Editas (EDIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026?

CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026...

Abercrombie & Fitch Upbeat Q1 Earnings, Joins Digital Turbine, Dycom Industries And Other Big Stocks Moving Higher On Wednesday

Dow Jones up 300 points with gains from Abercrombie & Fitch, Digital Turbine, Dycom Industries, Qfin Holdings, Editas Medicine, and others.read more...

EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus

Editas narrows Q1 loss as costs fall, but revenues drop sharply. Pipeline focus shifts to in vivo gene editing and lead candidate EDIT-401.

Company News for May 6, 2026

Companies in The News Are: MPC,EDIT,BUD,AEP

Chardan Capital Boosts Editas Medicine (NASDAQ:EDIT) Price Target to $4.00

Chardan Capital boosted their price objective on Editas Medicine from $3.50 to $4.00 and gave the stock a 'buy' rating in a research report on Tuesday...

Editas Medicine (NASDAQ:EDIT) Announces Earnings Results

Editas Medicine (NASDAQ:EDIT - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.26) earnings per share (EPS) for the quarter, beating analysts' consensus...

Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates

Editas (EDIT) delivered earnings and revenue surprises of +11.86% and -67.07%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Editas Medicine (EDIT) to Release Quarterly Earnings on Monday

Editas Medicine (NASDAQ:EDIT) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at...

Editas Medicine (NASDAQ:EDIT) Rating Increased to Hold at Wall Street Zen

Wall Street Zen raised shares of Editas Medicine from a 'sell' rating to a 'hold' rating in a research note on Saturday...

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu on September 3, 2013 and is headquartered in Cambridge, MA.

EDITEditas Medicine Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest EDIT News